CN Stock MarketDetailed Quotes

300463 Maccura Biotechnology

Watchlist
  • 13.14
  • -0.05-0.38%
Market Closed May 16 15:00 CST
8.05BMarket Cap25.47P/E (TTM)

Maccura Biotechnology Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

All
YOY yoy
Hide blank lines yoy
(Q3)Mar 31, 2024
(FY)Dec 31, 2023
(Q9)Sep 30, 2023
(Q6)Jun 30, 2023
(Q3)Mar 31, 2023
(FY)Dec 31, 2022
(Q9)Sep 30, 2022
(Q6)Jun 30, 2022
(Q3)Mar 31, 2022
(FY)Dec 31, 2021
Total operating revenue
-8.88%616.37M
-19.75%2.9B
-22.19%2.12B
-22.51%1.38B
-26.85%676.4M
-9.35%3.61B
-9.67%2.72B
-9.11%1.78B
-13.54%924.73M
7.47%3.98B
Operating revenue
-8.88%616.37M
-19.75%2.9B
-22.19%2.12B
-22.51%1.38B
-26.85%676.4M
-9.35%3.61B
-9.67%2.72B
-9.11%1.78B
-13.54%924.73M
7.47%3.98B
Other operating revenue
----
-15.50%33.95M
----
-8.67%18.31M
----
-13.54%40.18M
----
5.01%20.05M
----
18.81%46.47M
Total operating cost
-9.25%483.29M
-9.30%2.51B
-13.19%1.75B
-11.49%1.15B
-18.55%532.54M
-0.58%2.76B
1.11%2.02B
1.60%1.3B
-1.57%653.86M
2.19%2.78B
Operating cost
-13.13%262.5M
-21.58%1.3B
-25.72%953.2M
-20.88%643.7M
-28.35%302.17M
-1.32%1.65B
2.34%1.28B
-0.96%813.53M
-0.72%421.71M
-3.60%1.67B
Operating tax surcharges
-10.33%4.03M
-21.40%27.14M
-28.14%17.01M
-30.77%12.17M
-36.51%4.5M
-3.03%34.53M
-6.55%23.67M
0.32%17.58M
-15.91%7.08M
9.75%35.61M
Operating expense
-5.49%120.71M
3.58%652.41M
-0.05%428.47M
1.86%286.48M
-5.50%127.73M
-1.03%629.87M
1.30%428.66M
9.00%281.26M
-5.44%135.17M
19.49%636.43M
Administration expense
-2.63%32.69M
18.27%184.23M
16.35%117.54M
7.12%69.37M
-7.82%33.57M
-7.50%155.77M
2.39%101.02M
2.37%64.76M
2.26%36.42M
14.99%168.4M
Financial expense
-38.48%3.83M
27.46%23.31M
36.61%16.31M
-49.21%8.15M
-12.27%6.22M
-68.40%18.29M
-72.48%11.94M
-45.39%16.04M
-44.12%7.09M
-17.30%57.87M
-Interest expense (Financial expense)
-2.39%5.95M
-4.34%33.53M
-10.77%24.64M
-18.69%15.47M
-44.57%6.09M
-40.86%35.06M
-39.32%27.62M
-35.19%19.02M
-14.51%10.99M
-13.07%59.27M
-Interest Income (Financial expense)
10.43%-1.84M
16.45%-10.03M
20.64%-7.65M
31.23%-4.91M
59.91%-2.05M
-139.88%-12.01M
-153.26%-9.65M
-175.87%-7.14M
-272.97%-5.11M
-15.57%-5M
Research and development
2.02%59.52M
18.65%324.17M
30.17%217.17M
23.17%128.57M
25.80%58.35M
31.82%273.22M
12.14%166.83M
19.38%104.39M
16.45%46.38M
2.57%207.27M
Credit Impairment Loss
-280.58%-4.86M
-6.38%-36.37M
7.13%-19.07M
86.10%-1.68M
90.36%-1.28M
-254.60%-34.19M
-92.82%-20.54M
-22.82%-12.12M
-9.33%-13.26M
59.33%-9.64M
Asset Impairment Loss
98.15%-93.68K
-142.09%-58.04M
-534.05%-54.33M
-267.39%-49.42M
44.50%-5.06M
-35.95%-23.97M
-31.55%-8.57M
-117.01%-13.45M
-85.96%-9.11M
0.55%-17.63M
Other net revenue
194.88%3.36M
-110.55%-58.05M
-222.89%-59.34M
-253.14%-43.87M
82.56%-3.55M
-313.01%-27.57M
-2,625.03%-18.38M
-77.15%-12.42M
-50.59%-20.34M
124.76%12.94M
Fair value change income
78.08%-1.58M
22.27%-7.08M
-12.66%-15.39M
-856.58%-8.7M
---7.22M
---9.1M
---13.66M
---909.8K
----
--0
Invest income
-51.15%1.85M
-29.25%8.59M
-21.22%9.92M
30.42%7.9M
--3.79M
2,974.97%12.15M
2,539.81%12.59M
1,274.20%6.06M
----
-60.27%394.98K
-Including: Investment income associates
--0
-87.86%42.22K
-54.90%202.21K
-10.90%202.21K
--138.32K
-11.92%347.88K
186.87%448.36K
143.97%226.96K
----
-60.27%394.98K
Asset deal income
-258.71%-1.38M
-1.13%-4.17M
6.14%-3.15M
-0.15%-2.8M
-100.06%-386.04K
-1.74%-4.12M
-185.49%-3.36M
-404.96%-2.79M
74.01%-192.96K
-529.72%-4.05M
Other revenue
42.86%9.44M
23.17%39.01M
49.69%22.68M
0.36%10.82M
196.88%6.61M
-27.80%31.67M
4.62%15.15M
6.58%10.79M
-47.82%2.23M
-3.07%43.87M
Operating profit
-2.75%136.45M
-59.49%331.14M
-55.29%306.05M
-60.07%188.41M
-43.99%140.31M
-32.67%817.39M
-32.68%684.47M
-30.23%471.83M
-36.05%250.53M
22.67%1.21B
Add:Non operating Income
31.79%73.57K
-5.41%378.13K
-4.95%326.02K
196.18%134.75K
420.57%55.82K
-28.51%399.73K
31.02%343.01K
-65.61%45.49K
-76.54%10.72K
380.80%559.15K
Less:Non operating expense
-89.95%535.22K
-8.91%26.15M
-20.71%10.77M
28.69%6.04M
192.72%5.32M
4.41%28.71M
356.79%13.58M
126.86%4.69M
306.93%1.82M
37.21%27.5M
Total profit
0.70%135.98M
-61.30%305.37M
-55.96%295.6M
-60.93%182.51M
-45.71%135.04M
-33.53%789.08M
-33.80%671.23M
-30.72%467.18M
-36.44%248.72M
22.41%1.19B
Less:Income tax cost
-31.81%11.74M
-99.21%689.9K
-61.09%27.57M
-81.15%10.78M
-52.88%17.22M
-52.74%87.38M
-60.84%70.86M
-51.23%57.2M
-41.02%36.53M
24.57%184.88M
Net profit
5.45%124.24M
-56.58%304.68M
-55.36%268.03M
-58.11%171.73M
-44.47%117.83M
-29.99%701.71M
-27.93%600.37M
-26.40%409.98M
-35.58%212.19M
22.02%1B
Net profit from continuing operation
5.45%124.24M
-56.58%304.68M
-55.36%268.03M
-58.11%171.73M
-44.47%117.83M
-29.99%701.71M
-27.93%600.37M
-26.40%409.98M
-35.58%212.19M
22.02%1B
Less:Minority Profit
299.05%3.8M
-22.61%-7.94M
-147.77%-645.21K
-173.86%-3.11M
-90.79%952.67K
-114.19%-6.48M
-100.70%-260.41K
-83.41%4.21M
-35.55%10.34M
66.36%45.64M
Net profit of parent company owners
3.05%120.44M
-55.86%312.62M
-55.27%268.68M
-56.91%174.84M
-42.10%116.87M
-25.97%708.18M
-24.56%600.64M
-23.68%405.77M
-35.58%201.84M
20.49%956.6M
Earning per share
Basic earning per share
5.26%0.2
-56.20%0.5136
-55.72%0.4387
-57.57%0.2855
-44.10%0.19
-32.25%1.1726
-30.85%0.9907
-29.65%0.6728
-39.77%0.3399
20.77%1.7308
Diluted earning per share
5.26%0.2
-56.19%0.5104
-55.72%0.4387
-57.57%0.2855
-44.10%0.19
-32.18%1.1651
-30.70%0.9907
-29.53%0.6728
-39.58%0.3399
20.62%1.718
Other composite income
95.64%-363.65K
-152.74%-8.4M
-215.51%-16.91M
-129.41%-9.12M
-8.33M
472.55%15.93M
14.64M
31.03M
-133.89%-4.28M
Other composite income of parent company owners
95.64%-363.65K
-152.74%-8.4M
-215.51%-16.91M
-129.41%-9.12M
---8.33M
472.55%15.93M
--14.64M
--31.03M
----
-133.89%-4.28M
Total composite income
13.14%123.88M
-58.71%296.28M
-59.17%251.12M
-63.13%162.6M
-48.40%109.49M
-28.09%717.63M
-26.18%615.01M
-20.83%441.01M
-35.58%212.19M
19.67%997.97M
Total composite income of parent company owners
10.63%120.08M
-57.99%304.22M
-59.08%251.77M
-62.06%165.71M
-46.23%108.54M
-23.96%724.11M
-22.72%615.27M
-17.85%436.8M
-35.58%201.84M
18.08%952.33M
Total composite income of minority owners
299.05%3.8M
-22.61%-7.94M
-147.77%-645.21K
-173.86%-3.11M
-90.79%952.67K
-114.19%-6.48M
-100.70%-260.41K
-83.41%4.21M
-35.55%10.34M
66.36%45.64M
Currency Unit
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
Accounting Standards
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
Audit Opinions
--
Unqualified opinion
--
--
--
Unqualified opinion
--
--
--
Unqualified opinion
Auditor
--
Lixin Certified Public Accountants (Special General Partnership)
--
--
--
Lixin Certified Public Accountants (Special General Partnership)
--
--
--
Lixin Certified Public Accountants (Special General Partnership)
(Q3)Mar 31, 2024(FY)Dec 31, 2023(Q9)Sep 30, 2023(Q6)Jun 30, 2023(Q3)Mar 31, 2023(FY)Dec 31, 2022(Q9)Sep 30, 2022(Q6)Jun 30, 2022(Q3)Mar 31, 2022(FY)Dec 31, 2021
Total operating revenue -8.88%616.37M-19.75%2.9B-22.19%2.12B-22.51%1.38B-26.85%676.4M-9.35%3.61B-9.67%2.72B-9.11%1.78B-13.54%924.73M7.47%3.98B
Operating revenue -8.88%616.37M-19.75%2.9B-22.19%2.12B-22.51%1.38B-26.85%676.4M-9.35%3.61B-9.67%2.72B-9.11%1.78B-13.54%924.73M7.47%3.98B
Other operating revenue -----15.50%33.95M-----8.67%18.31M-----13.54%40.18M----5.01%20.05M----18.81%46.47M
Total operating cost -9.25%483.29M-9.30%2.51B-13.19%1.75B-11.49%1.15B-18.55%532.54M-0.58%2.76B1.11%2.02B1.60%1.3B-1.57%653.86M2.19%2.78B
Operating cost -13.13%262.5M-21.58%1.3B-25.72%953.2M-20.88%643.7M-28.35%302.17M-1.32%1.65B2.34%1.28B-0.96%813.53M-0.72%421.71M-3.60%1.67B
Operating tax surcharges -10.33%4.03M-21.40%27.14M-28.14%17.01M-30.77%12.17M-36.51%4.5M-3.03%34.53M-6.55%23.67M0.32%17.58M-15.91%7.08M9.75%35.61M
Operating expense -5.49%120.71M3.58%652.41M-0.05%428.47M1.86%286.48M-5.50%127.73M-1.03%629.87M1.30%428.66M9.00%281.26M-5.44%135.17M19.49%636.43M
Administration expense -2.63%32.69M18.27%184.23M16.35%117.54M7.12%69.37M-7.82%33.57M-7.50%155.77M2.39%101.02M2.37%64.76M2.26%36.42M14.99%168.4M
Financial expense -38.48%3.83M27.46%23.31M36.61%16.31M-49.21%8.15M-12.27%6.22M-68.40%18.29M-72.48%11.94M-45.39%16.04M-44.12%7.09M-17.30%57.87M
-Interest expense (Financial expense) -2.39%5.95M-4.34%33.53M-10.77%24.64M-18.69%15.47M-44.57%6.09M-40.86%35.06M-39.32%27.62M-35.19%19.02M-14.51%10.99M-13.07%59.27M
-Interest Income (Financial expense) 10.43%-1.84M16.45%-10.03M20.64%-7.65M31.23%-4.91M59.91%-2.05M-139.88%-12.01M-153.26%-9.65M-175.87%-7.14M-272.97%-5.11M-15.57%-5M
Research and development 2.02%59.52M18.65%324.17M30.17%217.17M23.17%128.57M25.80%58.35M31.82%273.22M12.14%166.83M19.38%104.39M16.45%46.38M2.57%207.27M
Credit Impairment Loss -280.58%-4.86M-6.38%-36.37M7.13%-19.07M86.10%-1.68M90.36%-1.28M-254.60%-34.19M-92.82%-20.54M-22.82%-12.12M-9.33%-13.26M59.33%-9.64M
Asset Impairment Loss 98.15%-93.68K-142.09%-58.04M-534.05%-54.33M-267.39%-49.42M44.50%-5.06M-35.95%-23.97M-31.55%-8.57M-117.01%-13.45M-85.96%-9.11M0.55%-17.63M
Other net revenue 194.88%3.36M-110.55%-58.05M-222.89%-59.34M-253.14%-43.87M82.56%-3.55M-313.01%-27.57M-2,625.03%-18.38M-77.15%-12.42M-50.59%-20.34M124.76%12.94M
Fair value change income 78.08%-1.58M22.27%-7.08M-12.66%-15.39M-856.58%-8.7M---7.22M---9.1M---13.66M---909.8K------0
Invest income -51.15%1.85M-29.25%8.59M-21.22%9.92M30.42%7.9M--3.79M2,974.97%12.15M2,539.81%12.59M1,274.20%6.06M-----60.27%394.98K
-Including: Investment income associates --0-87.86%42.22K-54.90%202.21K-10.90%202.21K--138.32K-11.92%347.88K186.87%448.36K143.97%226.96K-----60.27%394.98K
Asset deal income -258.71%-1.38M-1.13%-4.17M6.14%-3.15M-0.15%-2.8M-100.06%-386.04K-1.74%-4.12M-185.49%-3.36M-404.96%-2.79M74.01%-192.96K-529.72%-4.05M
Other revenue 42.86%9.44M23.17%39.01M49.69%22.68M0.36%10.82M196.88%6.61M-27.80%31.67M4.62%15.15M6.58%10.79M-47.82%2.23M-3.07%43.87M
Operating profit -2.75%136.45M-59.49%331.14M-55.29%306.05M-60.07%188.41M-43.99%140.31M-32.67%817.39M-32.68%684.47M-30.23%471.83M-36.05%250.53M22.67%1.21B
Add:Non operating Income 31.79%73.57K-5.41%378.13K-4.95%326.02K196.18%134.75K420.57%55.82K-28.51%399.73K31.02%343.01K-65.61%45.49K-76.54%10.72K380.80%559.15K
Less:Non operating expense -89.95%535.22K-8.91%26.15M-20.71%10.77M28.69%6.04M192.72%5.32M4.41%28.71M356.79%13.58M126.86%4.69M306.93%1.82M37.21%27.5M
Total profit 0.70%135.98M-61.30%305.37M-55.96%295.6M-60.93%182.51M-45.71%135.04M-33.53%789.08M-33.80%671.23M-30.72%467.18M-36.44%248.72M22.41%1.19B
Less:Income tax cost -31.81%11.74M-99.21%689.9K-61.09%27.57M-81.15%10.78M-52.88%17.22M-52.74%87.38M-60.84%70.86M-51.23%57.2M-41.02%36.53M24.57%184.88M
Net profit 5.45%124.24M-56.58%304.68M-55.36%268.03M-58.11%171.73M-44.47%117.83M-29.99%701.71M-27.93%600.37M-26.40%409.98M-35.58%212.19M22.02%1B
Net profit from continuing operation 5.45%124.24M-56.58%304.68M-55.36%268.03M-58.11%171.73M-44.47%117.83M-29.99%701.71M-27.93%600.37M-26.40%409.98M-35.58%212.19M22.02%1B
Less:Minority Profit 299.05%3.8M-22.61%-7.94M-147.77%-645.21K-173.86%-3.11M-90.79%952.67K-114.19%-6.48M-100.70%-260.41K-83.41%4.21M-35.55%10.34M66.36%45.64M
Net profit of parent company owners 3.05%120.44M-55.86%312.62M-55.27%268.68M-56.91%174.84M-42.10%116.87M-25.97%708.18M-24.56%600.64M-23.68%405.77M-35.58%201.84M20.49%956.6M
Earning per share
Basic earning per share 5.26%0.2-56.20%0.5136-55.72%0.4387-57.57%0.2855-44.10%0.19-32.25%1.1726-30.85%0.9907-29.65%0.6728-39.77%0.339920.77%1.7308
Diluted earning per share 5.26%0.2-56.19%0.5104-55.72%0.4387-57.57%0.2855-44.10%0.19-32.18%1.1651-30.70%0.9907-29.53%0.6728-39.58%0.339920.62%1.718
Other composite income 95.64%-363.65K-152.74%-8.4M-215.51%-16.91M-129.41%-9.12M-8.33M472.55%15.93M14.64M31.03M-133.89%-4.28M
Other composite income of parent company owners 95.64%-363.65K-152.74%-8.4M-215.51%-16.91M-129.41%-9.12M---8.33M472.55%15.93M--14.64M--31.03M-----133.89%-4.28M
Total composite income 13.14%123.88M-58.71%296.28M-59.17%251.12M-63.13%162.6M-48.40%109.49M-28.09%717.63M-26.18%615.01M-20.83%441.01M-35.58%212.19M19.67%997.97M
Total composite income of parent company owners 10.63%120.08M-57.99%304.22M-59.08%251.77M-62.06%165.71M-46.23%108.54M-23.96%724.11M-22.72%615.27M-17.85%436.8M-35.58%201.84M18.08%952.33M
Total composite income of minority owners 299.05%3.8M-22.61%-7.94M-147.77%-645.21K-173.86%-3.11M-90.79%952.67K-114.19%-6.48M-100.70%-260.41K-83.41%4.21M-35.55%10.34M66.36%45.64M
Currency Unit CNYCNYCNYCNYCNYCNYCNYCNYCNYCNY
Accounting Standards CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)
Audit Opinions --Unqualified opinion------Unqualified opinion------Unqualified opinion
Auditor --Lixin Certified Public Accountants (Special General Partnership)------Lixin Certified Public Accountants (Special General Partnership)------Lixin Certified Public Accountants (Special General Partnership)

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
CN
Overall
Symbol
Latest Price
%Chg